Orexigenic peptides Flashcards

1
Q

What are orexigenic peptides named after?

A

Peptides having an orexigenic effect – stimulating the appetite or
increasing food intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the role of energy homeostasis?

A

Gut-brain axis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe leptin

A
  • NOT a neuropeptide
  • Discovered as a spontaneous
    mutation in a mouse line at Jackson
    labs in 1949
  • Obese mice (ob/ob) carried a
    recessive mutation leading to
    spontaneous hyperphagy and weight
    gain
  • Later identified as a mutation in the
    leptin gene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe leptin’s orexilytic effects

A
  • Leptin is a 16 kDa (167 amino acids) protein hormone released from
    adipose tissue to attenuate appetite
  • Release signals from site of energy storage to decrease caloric
    intake
  • Leptin receptors are found in the arcuate nucleus of the
    hypothalamus (main site of action)
  • Inability to signal satiety in ob/ob mice leads to constant hunger
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe neuropeptide y

A
  • Expressed from the NPY gene as
    preproNPY
  • NPY, C-flanking peptide, and
    CPON
  • Identified in 1982 in the porcine
    hypothalamus
  • NPY expression is highest in the
    arcuate nucleus of the
    hypothalamus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the therapeutic potential of NPY

A
  • NPY, as with other neuropeptides, has poor pharmacokinetics
  • Short half-life in circulation
  • IV administration required (peptides are both highly hydrophilic and sensitive to acid hydrolysis)
  • Pharmacodynamic tolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What genes does ghrelin express?

A
  • GHRL gene expresses preproghrelin and obestatin (which may not have
    much to do with obesity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe GHRL receptors

A

Ghrelin acts at the growth hormone
secretagogue type 1A receptor
(GHSR).

Ghrelin was identified as
endogenous agonist for the GHSR
(hence the disparity in naming).

GHSR is expressed widely in the
periphery (esp. vagus nerve) and in
the CNS on NPY secreting cells of the
arcuate nucleus of the hypothalamus.

GHSR activation leads to secretion of
NPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe orexigenic effects of ghrelin

A
  • Systemic administration of ghrelin
    increases food intake
  • Gastric bypass surgery decreases
    ghrelin levels in obese patients
  • Ghrelin also interacts with
    numerous aspects of mood, stress,
    and diet to affect food intake
  • Ghrelin increases hedonic aspects
    of food intake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe GHSR expression in CNS

A
  • In addition to the hypothalamus, GHSR is expressed in
    the ventral tegmental area, substantia nigra, raphe
    nuclei, hippocampus (dentate gyrus)
  • Ghrelin has pronounced effects on the mesolimbic
    cholinergic-dopaminergic reward network
  • Natural role for ghrelin in signalling reinforcing aspects of
    food reward
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe post translational modification of GHRL

A

Enzyme responsible for acylation is
Ghrelin-O-acyltransferase (GOAT).

GOAT activity increases after intake of
medium-chain fatty acids in the diet –
leading to increased acylation of
ghrelin and increasing huger stimuli.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe ghrelin and sleep

A
  • Ghrelin expression has a negative correlation with sleep time
  • Decreased sleep leads to elevated ghrelin
  • Increased sleep leads to decreased ghrelin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe long term changes in ghrelin

A
  • Ghrelin release is also inversely proportional to body weight
  • Weight loss leads to increased ghrelin release
  • Weight gain leads to decreased ghrelin release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe GHRL and addictions

A
  • Ghrelin is involved in reinforcing aspects of food
  • Ghrelin also involved in signalling reinforcing aspects of alcohol
  • Expected as alcohol is also a high calorie vice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe operant conditioning apparatus

A

Modified Skinner box

Used to study motivation to self-administer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe breaking point

A
  • The highest completed ratio of demand to response
    is termed the break point
  • Break point reflects motivation – amount of work
    willing to perform to achieve reward
  • Ghrelin administration increases the break point of
    heroin self-administration
17
Q

Describe conditioned place preference

A
  • Ghrelin administration alone can induce a CPP in
    animal models
18
Q

Describe orexin

A
  • Two peptides (orexin A/B or hypocretin 1/2) formed from a
    single prepropeptide off the HCRT gene
19
Q

Where are orexin secreting neurons found?

A

lateral
hypothalamus but extensively
innervate the brain and spinal
cord.

20
Q

Describe orexin’s orexigenic effects

A
  • Orexigenic
  • Orexin neurons are downstream of ghrelin and leptin sensitive neurons of the arcuate nucleus
  • Ghrelin & NPY stimulate orexin release
  • Leptin & CART inhibit orexin release
  • Orexin k/o mice show no orexigenic effects of ghrelin administration
21
Q

Describe orexin and wakefulness

A
  • Orexinergic neurons receive indirect input from suprachiasmic nucleus (SCN) – important in
    circadian rhythms
  • Orexin projects to systems involved in wakefulness
  • Locus ceruleus norepinephrine systems
  • Dorsal raphe seratonin systems
  • Tuberomamillary histamine systems
  • Basal forebrain cholinergic system (BFCS)
22
Q

Describe pharmacological targets for sleep disorder

A
  • Suvorexant is an OX receptor antagonist (dual orexin receptor
    antagonists, DORA) for insomnia treatment
  • Almorexant was a DORA developed by GlaxoSmithKline –
    discontinued in 2011 during phase III trials for unspecified reasons (likely adverse side effects)
23
Q

Describe orexin and addictions

A
  • OX receptor antagonists decrease self-administration of alcohol, opiates,
    nicotine
24
Q

Describe orexins and emotional memory

A
  • Orexin k/o mice show decreased responses to intruder mice, air-jet stress
  • Proposed to maintain wakefulness in response to emotional arousal via limbic
    inputs
25
Q

Describe orexin and motivational activation

A
  • Roles of orexin in food intake and wakefulness suggest involvement in motivational activation
  • Phasic orexin activity increases during adaptive behaviour
  • Exploration, play, predation, grooming
  • Does not increase during activities matched for physiological arousal and locomotion